We in this study investigated in women with various forms of ovarian cancer whether the presence of BRCA1/2 mutations resulted in enrichment of low FMR1 mutations, which would suggest interplay between these two genes, in establishing oncogenic risk. This evidence concerns the gene FMR1 and ovarian carcinoma.